UK markets closed

ERYTECH Pharma S.A. (0QSS.L)

LSE - LSE Delayed price. Currency in EUR
Add to watchlist
0.6919-0.5182 (-42.82%)
At close: 05:09PM GMT
Full screen
Loading interactive chart…
  • Globe Newswire

    ERYTECH Provides Business and Financial Update for the Third Quarter of 2022

    ERYTECH Provides Business and Financial Update for the Third Quarter of 2022 Conference call and webcast on Tuesday, November 22, 2022at 8:30am ET / 02:30pm CET Lead program Graspa halted Focus on preclinical programs and partnering optionsDeep restructuring implemented; team size reduced by approximately 75% since start of year Cash and cash equivalents of €47.3 million ($46.3 million) at the end of September 2022 Cambridge, MA (U.S.) and Lyon (France), November 21, 2022 – ERYTECH Pharma (Nasda

  • Globe Newswire

    ERYTECH Announces Receipt of Nasdaq Notice

    ERYTECH Announces Receipt of Nasdaq Notice Cambridge, MA (U.S.) and Lyon (France), October 13, 2022 – ERYTECH Pharma (Nasdaq & Euronext: a clinical-stage biopharmaceutical company developing innovative therapies by encapsulating therapeutic drug substances inside red blood cells, today announced that it received written notification (the “Notification Letter”) from The Nasdaq Stock Market LLC ("Nasdaq") dated October 7, 2022, indicating that, based upon a closing bid price of less than $1.00 per

  • Zacks

    Erytech Pharma SA Sponsored ADR (ERYP) Upgraded to Buy: Here's Why

    Erytech Pharma SA Sponsored ADR (ERYP) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.